ArticleFuture healthcare journal2025
Commercial influences on infant and young child feeding.
Article in Future healthcare journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Profits Before Health? New Zealand Government Rejection of Stricter Infant Formula Marketing Standards and the Lobbying Behind It.Maternal & child nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Optimal infant and young child feeding is essential for child health, development and social wellbeing. Breastfeeding is the foundation of early nutrition, and powerfully protects infants and young children against both infectious and non-communicable diseases. The commercial milk formula industry systematically undermines breastfeeding through pervasive marketing and influence over science, education and policy, despite international guidance, including the World Health Organization (WHO) International Code of Marketing of Breast-milk Substitutes. Biased industry-sponsored research supports misleading claims about formula efficacy, while industry funding of nutrition regulators, professional education and healthcare practitioners creates conflicts of interest. To protect public health, stronger regulations, full implementation of the WHO Code and clear boundaries between the formula industry and health sectors are needed. We propose policy actions, including a binding global treaty and transparency measures, to counteract commercial influence and safeguard child health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.